The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
摘要:
Optimization of a series of constrained melanin-concentrating hormone receptor 1 (MCH RI) antagonists has provided compounds with potent and selective MCH R1 activity. Details of the optimization process are provided and the use of one of the compounds in an animal model of diet-induced obesity is presented. (c) 2006 Elsevier Ltd. All rights reserved.
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
摘要:
Optimization of a series of constrained melanin-concentrating hormone receptor 1 (MCH RI) antagonists has provided compounds with potent and selective MCH R1 activity. Details of the optimization process are provided and the use of one of the compounds in an animal model of diet-induced obesity is presented. (c) 2006 Elsevier Ltd. All rights reserved.
Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity
作者:William McCoull、Peter Barton、Anders Broo、Alastair J. H. Brown、David S. Clarke、Gareth Coope、Robert D. M. Davies、Alexander G. Dossetter、Elizabeth E. Kelly、Laurent Knerr、Philip MacFaul、Jane L. Holmes、Nathaniel Martin、Jane E. Moore、David Morgan、Claire Newton、Krister Österlund、Graeme R. Robb、Eleanor Rosevere、Nidhal Selmi、Stephen Stokes、Tor S. Svensson、Victoria B. K. Ullah、Emma J. Williams
DOI:10.1039/c2md20340e
日期:——
A pyrazolo-pyrimidinone based series of growth hormone secretagogue receptor type 1a (GHS-R1a) antagonists and inverse agonists were identified using a scaffold hop from known quinazolinone GHS-R1a modulators. Lipophilicity was reduced to decrease hERG activity while maintaining GHS-R1a affinity. SAR exploration of a piperidine substituent was used to identify small cyclic groups as a functional switch from partial agonists to neutral antagonists and inverse agonists. A tool compound was identified which had good overall properties and sufficient oral plasma and CNS exposure to demonstrate reduced food intake in mice through a mechanism involving GHS-R1a.
[EN] PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1<br/>[FR] PYRIMIDINONES EN TANT QUE RECEPTEUR 1 DE L'HORMONE DE CONCENTRATION DE LA MELANINE
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2003033476A1
公开(公告)日:2003-04-24
A compound of formula (Ia) comprising a pharmaceutically acceptable salt or solvate thereof, formulations, processes of preparing, and methods of administering to mammals are provided
本发明提供了化合物(Ia)的配方,包括其药物可接受的盐或溶剂,制备过程和哺乳动物的给药方法。
Pyrimidinones as melanin concentrating hormone receptor 1
申请人:——
公开号:US20040220404A1
公开(公告)日:2004-11-04
A compound of formula (Ia) comprising a pharmaceutically acceptable salt or solvate thereof, formulations, processes of preparing, and methods of administering to mammals are provided
1
提供了一种化合物(Ia)的配方,包括其药用可接受的盐或溶剂,制备过程以及对哺乳动物的给药方法。
PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1